Find Grants for Native American & Tribal Governments

Find out if you qualify for verified grants for Native American & Tribal Governments. Discover your eligibility and key funding details for Native American & Tribal Governments from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Deadline: May 7, 2027


Opportunity Number: PAR-24-329

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.279

HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)

Deadline: November 23, 2026


Opportunity Number: RFA-AT-25-003

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: November 23, 2026

Status: Posted

CFDA Numbers: 93.121, 93.865, 93.866, 93.213, 93.273, 93.846, 93.853

Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PA-25-150

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.853, 93.242

NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)

Deadline: January 7, 2028


Opportunity Number: PAR-25-250

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.173

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-068

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.847

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAS-25-073

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.847

Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)

Deadline: May 7, 2026


Opportunity Number: PAS-25-102

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.847

Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

Deadline: May 7, 2026


Opportunity Number: PA-25-169

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.867, 93.286, 93.866

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-377

Agency: National Institutes of Health

Open Date: January 8, 2025

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.121, 93.313, 93.361, 93.866, 93.393, 93.307

Findable Accessible Interoperable Reusable Open Science

Deadline: April 8, 2026


Opportunity Number: 25-533

Agency: U.S. National Science Foundation

Open Date: January 7, 2025

Close Date: April 8, 2026

Status: Posted

CFDA Numbers: 47.079, 47.084, 47.070, 47.041, 47.083, 47.049, 47.075, 47.076, 47.050, 47.074

Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)

Deadline: October 1, 2026


Opportunity Number: RFA-DC-25-003

Agency: National Institutes of Health

Open Date: January 6, 2025

Close Date: October 1, 2026

Status: Posted

CFDA Numbers: 93.173

In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)

Deadline: October 1, 2026


Opportunity Number: RFA-DC-25-005

Agency: National Institutes of Health

Open Date: January 6, 2025

Close Date: October 1, 2026

Status: Posted

CFDA Numbers: 93.173

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

Deadline: September 7, 2028


Opportunity Number: PAR-25-324

Agency: National Institutes of Health

Open Date: January 6, 2025

Close Date: September 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.396, 93.395, 93.399, 93.394, 93.397

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

Deadline: October 18, 2027


Opportunity Number: PAR-25-343

Agency: National Institutes of Health

Open Date: January 6, 2025

Close Date: October 18, 2027

Status: Posted

CFDA Numbers: 93.173

Cybersecurity Innovation for Cyberinfrastructure

Deadline: January 21, 2026


Opportunity Number: 25-531

Agency: U.S. National Science Foundation

Open Date: January 4, 2025

Close Date: January 21, 2026

Status: Posted

CFDA Numbers: 47.070

FY2025 NAGPRA Repatriation Grants

Deadline: May 8, 2026


Opportunity Number: P25AS00474

Agency: National Park Service

Open Date: January 3, 2025

Close Date: May 8, 2026

Status: Posted

CFDA Numbers: 15.922

NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Deadline: November 5, 2026


Opportunity Number: PAR-25-089

Agency: National Institutes of Health

Open Date: January 3, 2025

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.847

NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)

Deadline: November 5, 2026


Opportunity Number: PA-25-147

Agency: National Institutes of Health

Open Date: January 3, 2025

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.847

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

Deadline: October 16, 2027


Opportunity Number: PAR-25-357

Agency: National Institutes of Health

Open Date: January 2, 2025

Close Date: October 16, 2027

Status: Posted

CFDA Numbers: 93.867

Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)

Deadline: May 7, 2028


Opportunity Number: PA-25-280

Agency: National Institutes of Health

Open Date: January 2, 2025

Close Date: May 7, 2028

Status: Posted

CFDA Numbers: 93.173, 93.286, 93.847, 93.866, 93.233, 93.113, 93.351, 93.213, 93.867, 93.273

Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-347

Agency: National Institutes of Health

Open Date: January 2, 2025

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.279

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-338

Agency: National Institutes of Health

Open Date: December 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.395, 93.867, 93.121, 93.313, 93.394

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-337

Agency: National Institutes of Health

Open Date: December 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.395

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Deadline: August 11, 2027


Opportunity Number: PAR-25-101

Agency: National Institutes of Health

Open Date: December 30, 2024

Close Date: August 11, 2027

Status: Posted

CFDA Numbers: 93.279

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Deadline: January 7, 2029


Opportunity Number: PAR-25-362

Agency: National Institutes of Health

Open Date: December 30, 2024

Close Date: January 7, 2029

Status: Posted

CFDA Numbers: 93.865

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.